Possible alternative to antibiotics produced by bacteria
- Details
- Category: Research
Kaposi sarcoma discovery could facilitate drug development
- Details
- Category: Research
The findings appeared in Cell Host & Microbe.
Healthy lifestyle may offset effects of life-shortening genes by 60%+
- Details
- Category: Research
While genes and lifestyle seem to have an additive effect on a person's lifespan, an unhealthy lifestyle is independently linked to a 78% heightened risk of dying before one’s time, regardless of genetic predisposition, the research indicates.
U.S. FDA approves Pfizer's BEQVEZ™ (fidanacogene elaparvovec-dzkt), a one-time gene therapy for adults with Hemophilia B
- Details
- Category: Pfizer
AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in congestive heart failure
- Details
- Category: Bayer
Researchers publish final results of key clinical trial for gene therapy for sickle cell disease
- Details
- Category: Research
Optimal timing maximises Paxlovid benefits for treating COVID-19
- Details
- Category: Research
The findings suggest that taking Paxlovid three to five days after COVID-19 symptoms emerge may maximise the drug's ability to reduce viral loads, minimise viral spread and reduce viral rebound.
European Commission approves Pfizer's EMBLAVEO® for patients with multidrug-resistant infections and limited treatment options
- Details
- Category: Pfizer
Researchers develop a new way to safely boost immune cells to fight cancer
- Details
- Category: Research
Immunotherapy is on the rise as a possible solution. Immunotherapy involves harnessing the power of the body's immune system to fight against cancer cells.
How the Birmingham Drug Discovery Hub created an investment-ready 'drug library'
- Details
- Category: Research
The approach, detailed in a feature published in the April issue of Drug Discovery Today, has attracted more than £4m in industry funding, grants and industry awards, on the back of just £0.2m investment from the University's Dynamic Investment Fund (DIF).